What gland(s) secrete(s) alkaline fluid to neutralize urine in the urethra?

A. spermatocytes: These are intermediate cells in the process of spermatogenesis that undergo meiotic division to eventually become spermatids. They are located within the seminiferous tubules and are sequestered from the systemic circulation by the blood-testis barrier. Their primary function is genetic reduction rather than the biosynthesis of steroid hormones.

B. sustentacular cells: Also known as Sertoli cells, these provide structural and nutritional support to developing sperm within the seminiferous tubules. They produce androgen-binding protein and inhibin under the influence of follicle-stimulating hormone. While they facilitate the action of testosterone, they are not the primary site of its synthesis.

C. spermatogonia: These represent the stem cell population of the testes that undergo mitosis to maintain the germ cell line. They are diploid cells located on the basement membrane of the seminiferous tubules. They possess no endocrine capability and serve exclusively as the precursors for the male gametic lineage.

D. macula densa cells: These are specialized chemoreceptor cells located in the distal convoluted tubule of the kidney. They function within the juxtaglomerular apparatus to monitor sodium chloride concentration in the renal filtrate. They have no physiological presence or function within the male reproductive system or the testes.

E. interstitial endocrine cells: Also called Leydig cells, these are situated in the connective tissue spaces surrounding the seminiferous tubules. In response to luteinizing hormone from the anterior pituitary, they synthesize and secrete testosterone. This androgen is essential for both spermatogenesis and the maintenance of male secondary sexual characteristics.

examinations, self-exams, and mammography. A Pap smear involves collecting cells from the reproductive tract and cannot detect malignant transformations within the glandular tissue of the breast. These two screening processes target entirely different organ systems.

B. uterine cancer: While a Pap smear may occasionally pick up abnormal endometrial cells, it is not the standard diagnostic tool for uterine or endometrial cancer. Endometrial biopsy or transvaginal ultrasound are the preferred methods for evaluating the uterine lining. The Pap smear specifically targets the squamous and columnar cells of the lower tract.

C. penile cancer: This rare malignancy is usually identified through visual inspection and biopsy of lesions on the glans or shaft of the penis. The Pap smear is a gynecological procedure designed for female anatomy. There is no equivalent cytological brush test used as a standard screening for penile tissue in asymptomatic males.

D. testicular cancer: Testicular cancer is typically detected through physical palpation, scrotal ultrasound, and blood markers such as alpha-fetoprotein. Because the testes are sequestered within the scrotum and do not shed cells into a mucosal canal, a cytological smear is not a viable method for detecting these tumors.

E. cervical cancer: The Papanicolaou smear is a cytological screening test specifically designed to detect premalignant and malignant cells in the ectocervix and endocervical canal. By examining cells scraped from the transformation zone, clinicians can identify human papillomavirus (HPV) induced changes. This test has significantly reduced the mortality rate associated with cervical malignancy.